S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|GlaxoSmithKline Sells Stake in Denmark's Genmab (2015/2/5)|
|Genmab: 4Q Sales of Arzerra Leukaemia Drug at GBP12.3 Million (2015/2/4)|
|GlaxoSmithKline to Sell Genmab Stake (2015/2/4)|
|Glaxo to Sell Stake in Cancer Drug Developer for GBP194 Million (2015/2/5)|
|DataCore Software Adds Emulex Gen 5 Fibre Channel Technology to New SANsymphony-V10 Software-defined Storage Platform (2015/1/28)|
|Power Solutions International Launches Newly Designed 4.3-Liter and 180kW 8.8-Liter Engines at POWER-GEN (2014/12/8)|
|Genocea Completes Enrollment Early in Phase 2 Dose Optimization Trial of GEN-003 for Treatment of Genital Herpes (2015/1/7)|
|Weber Shandwick Identifies Critical Crossroad in Generation X Retirement Planning: The Intersection of Health and Wealth (2014/12/5)|
|Celsion Corporation Submits DNA-based Immunotherapy Clinical Protocol to the FDA as Part of a First Line Treatment for Ovarian Cancer (2015/1/6)|
|Emulex Gains Fibre Channel Market Share (2015/2/6)|
Click above to view more mutual fund data and stats for gen - Genmab A/S.